» Articles » PMID: 34370710

Seroprevalence of Dengue Infection Using IgG Capture ELISA in India, 2017-2018

Abstract

We conducted a nationally representative population-based survey in 60 districts from 15 Indian states covering all five geographic regions during 2017-2018 to estimate the age specific seroprevalence of dengue. Of the 12,300 sera collected, 4,955 were positive for IgG antibodies against dengue virus using IgG Indirect ELISA indicating past dengue infection. We tested 4,948 sera (seven had inadequate volume) positive for IgG antibodies on indirect ELISA using anti-dengue IgG capture ELISA to estimate the proportion of dengue infections with high antibody titers, suggestive of acute or recent secondary infection. Of the 4,948 sera tested, 529 (10.7%; 95% CI: 9.4-12.1) were seropositive on IgG capture ELISA. The proportions of dengue infections with high titers were 1.1% in the northeastern, 1.5% in the eastern, 6.2% in the western, 12.2% in the southern, and 16.7% in the northern region. The distribution of dengue infections varied across geographic regions, with a higher proportion of infections with high antibody titer in the northern and southern regions of India. The study findings could be useful for planning facilities for clinical management of dengue infections.

Citing Articles

Attrition in serum anti-DENV antibodies correlates with high anti-SARS-CoV-2 IgG levels and low DENV positivity in mosquito vectors-Findings from a state-wide cluster-randomized community-based study in Tamil Nadu, India.

Selvavinayagam S, Sankar S, Yong Y, Anshad A, Chandramathi S, Somasundaram A PLOS Glob Public Health. 2024; 4(11):e0003608.

PMID: 39570962 PMC: 11581277. DOI: 10.1371/journal.pgph.0003608.


Temporal cytokine storm dynamics in dengue infection predicts severity.

Bhatt P, Varma M, Sood V, Ambikan A, Jayaram A, Babu N Virus Res. 2024; 341:199306.

PMID: 38176525 PMC: 10818250. DOI: 10.1016/j.virusres.2023.199306.


Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study.

Tsai J, Tsai C, Lin P, Chen C, Tsai W, Dai Y BMC Infect Dis. 2023; 23(1):301.

PMID: 37158835 PMC: 10165301. DOI: 10.1186/s12879-023-08307-8.